Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2004 2
2005 5
2006 7
2007 9
2008 11
2009 15
2010 13
2011 16
2012 10
2013 6
2014 12
2015 9
2016 11
2017 14
2018 14
2019 15
2020 13
2021 11
2022 12
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean manuel f jimenez navarro (78 results)?
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. Cosentino F, et al. Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486. Eur Heart J. 2020. PMID: 31497854 Review. No abstract available.
Mesothelial-mesenchymal transitions in embryogenesis.
Carmona R, Ariza L, Cano E, Jiménez-Navarro M, Muñoz-Chápuli R. Carmona R, et al. Among authors: jimenez navarro m. Semin Cell Dev Biol. 2019 Aug;92:37-44. doi: 10.1016/j.semcdb.2018.09.006. Epub 2018 Sep 26. Semin Cell Dev Biol. 2019. PMID: 30243860 Review.
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
Bermejo J, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subías P, San Román JA, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, de Teresa E, González-Juanatey JR, Evangelista A, Mombiela T, González-Mansilla A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators. Bermejo J, et al. Eur Heart J. 2018 Apr 14;39(15):1255-1264. doi: 10.1093/eurheartj/ehx700. Eur Heart J. 2018. PMID: 29281101 Free PMC article. Clinical Trial.
Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.
Molina-Ramos AI, Gómez-Moyano E, Rodríguez-Capitán J, Angullo-Gómez M, Gallardo-Jiménez P, Pérez de Pedro I, Valiente de Santis L, Pérez-Villardón B, Piñero-Uribe I, Mora-Robles J, Becerra-Muñoz VM, Jiménez-Navarro M. Molina-Ramos AI, et al. Among authors: jimenez navarro m. J Clin Med. 2022 Nov 26;11(23):6999. doi: 10.3390/jcm11236999. J Clin Med. 2022. PMID: 36498573 Free PMC article. Review.
Comments on the 2019 ESC guidelines on supraventricular tachycardia.
SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia, Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia, SEC Guidelines Committee; SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia; Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia; SEC Guidelines Committee. SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia, Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia, SEC Guidelines Committee, et al. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):445-451. doi: 10.1016/j.rec.2019.12.024. Epub 2020 Apr 26. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32349912 English, Spanish. No abstract available.
Comments on the 2019 ESC guidelines on acute pulmonary embolism.
Working Group of the SEC for the 2019 ESC guidelines on acute pulmonary embolism, Expert Reviewers for the 2019 ESC guidelines on acute pulmonary embolism, and the SEC Guidelines Committee; Working Group of the SEC for the 2019 ESC guidelines on acute pulmonary embolism; SEC Guidelines Committee. Working Group of the SEC for the 2019 ESC guidelines on acute pulmonary embolism, Expert Reviewers for the 2019 ESC guidelines on acute pulmonary embolism, and the SEC Guidelines Committee, et al. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):452-456. doi: 10.1016/j.rec.2019.12.022. Epub 2020 Apr 27. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32349911 English, Spanish. No abstract available.
Comments on the 2019 ESC guidelines on chronic coronary syndromes.
SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines Committe; SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes; SEC Guidelines Committee. SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines Committe, et al. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):439-444. doi: 10.1016/j.rec.2019.12.023. Epub 2020 May 4. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32376227 English, Spanish. No abstract available.
Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias.
SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe; Grupo de Trabajo de la SEC para la guía ESC 2019 sobre el tratamiento de las dislipemias; Revisores expertos para la ESC 2019 sobre el tratamiento de las dislipemias; Comité de Guías de la SEC. SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe, et al. Rev Esp Cardiol (Engl Ed). 2020 May;73(5):348-353. doi: 10.1016/j.rec.2019.11.019. Epub 2020 Mar 21. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32205101 English, Spanish. No abstract available.
193 results